13F Pro

SEC Form 4 reporting owner

Levy Richard S

Levy Richard S has filed 22 Form 4 transactions reported between January 26, 2026 and August 1, 2026, as a reporting owner of Kiniksa Pharmaceuticals International, plc, a reporting owner of Kodiak Sciences Inc., Director of MADRIGAL PHARMACEUTICALS, INC. and a reporting owner of Protara Therapeutics, Inc..

Name as filed: Levy Richard S

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$2.9M
11 lines
Companies
4
with Form 4 filings
Latest transaction
Aug 1, 2026
transaction date

Roles and reported holdings

  • KNSAKiniksa Pharmaceuticals International, plc
    Feb 1, 2026 – Aug 1, 2026

    Reporting owner

    No common-stock holding reported on a purchase, sale, gift or withholding line.

  • KODKodiak Sciences Inc.
    Jun 30, 2026

    Reporting owner

    No common-stock holding reported on a purchase, sale, gift or withholding line.

  • MDGLMADRIGAL PHARMACEUTICALS, INC.
    Jan 26, 2026 – Jun 17, 2026

    Director

    Held directly22,015 sh as of May 22, 2026 · Form 4

    24 months: $2.9M sold

  • TARAProtara Therapeutics, Inc.
    Jun 15, 2026

    Reporting owner

    No common-stock holding reported on a purchase, sale, gift or withholding line.

Transaction history

All 22 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Aug 1, 2026KNSAOption exerciseCode M · direct403—Form 4
Jun 30, 2026KODGrant or awardCode A · direct17,731—Form 4
Jun 17, 2026MDGLDirectorGrant or awardCode A · direct766—Form 4
Jun 17, 2026MDGLDirectorGrant or awardCode A · direct454—Form 4
Jun 15, 2026TARAGrant or awardCode A · direct31,000—Form 4
May 29, 2026KNSAGrant or awardCode A · direct2,026—Form 4
May 29, 2026KNSAGrant or awardCode A · direct12,158—Form 4
May 29, 2026KNSAOption exerciseCode M · direct2,799—Form 4
May 22, 2026MDGLDirectorOpen-market saleCode S · direct80$42K@ $519.98Form 4
May 22, 2026MDGLDirectorOpen-market saleCode S · direct782$406K@ $518.76Form 4
May 22, 2026MDGLDirectorOpen-market saleCode S · direct1,497$775K@ $517.59Form 4
May 22, 2026MDGLDirectorOpen-market saleCode S · direct723$374K@ $516.87Form 4
May 22, 2026MDGLDirectorOpen-market saleCode S · direct657$339K@ $515.92Form 4
May 22, 2026MDGLDirectorOpen-market saleCode S · direct343$177K@ $514.67Form 4
May 22, 2026MDGLDirectorOpen-market saleCode S · direct439$225K@ $512.50Form 4
May 22, 2026MDGLDirectorOpen-market saleCode S · direct610$312K@ $511.40Form 4
May 22, 2026MDGLDirectorOpen-market saleCode S · direct151$77K@ $510.36Form 4
May 22, 2026MDGLDirectorOpen-market saleCode S · direct320$163K@ $508.24Form 4
May 22, 2026MDGLDirectorOpen-market saleCode S · direct40$20K@ $506.68Form 4
Feb 23, 2026MDGLDirectorOption exerciseCode M · direct2,500$18K@ $7.36Form 4
Feb 1, 2026KNSAOption exerciseCode M · direct683—Form 4
Jan 26, 2026MDGLDirectorOption exerciseCode M · direct4,000$66K@ $16.46Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.